Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Czechia Clear all

245 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20033
20045
20058
20069
20077
200815
200915
201024
201115
201220
201314
20149
201513
20169
201713
20184
201910
20209
20216
20225
20237
20244
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed199
Terminated19
Recruiting12
Active, not recruiting9
Unknown status3
Withdrawn1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S47
Eli Lilly and Company30
AstraZeneca27
Sanofi19
Boehringer Ingelheim17
Takeda12
Institute for Clinical and Experimental Medicine9
GlaxoSmithKline8
Janssen Research & Development, LLC6
Hoffmann-La Roche5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2245
Diabetes Mellitus63
Obesity22
Glucose Metabolism Disorders12
Cardiovascular Diseases11
Overweight11
Diabetes Mellitus, Type 110
Renal Insufficiency, Chronic9
Diabetic Nephropathies8
Hyperglycemia8

Trials

Showing 26 to 50 of 245. Each trial links to its page on Pharma Observatory.

145 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.